Literature DB >> 8043331

Usefulness of arterial blood gas estimations during exercise in patients with chronic heart failure.

A L Clark1, A J Coats.   

Abstract

BACKGROUND: Coexisting cardiorespiratory disease may contribute in individual cases to the increased ventilatory response to exercise in patients with chronic heart failure.
OBJECTIVE: To characterise further the arterial blood gas response to exercise and to explore the possible uses of blood gas sampling in clinical practice in patients with chronic heart failure.
METHODS: 37 patients with a primary diagnosis of chronic heart failure (age (range) 59 (45-80); left ventricular ejection fraction 24.5% (4%-44%)) underwent exercise testing with arterial blood gas analysis during exercise.
RESULTS: In 34 patients there was a small fall in arterial carbon dioxide tension from a mean (SEM) of 4.9 (0.1) kPa at rest to 4.6 (0.1) kPa at peak exercise (p < 0.001). There was no significant change in arterial oxygen tension. During the recovery period arterial oxygen tension rose from 13.3 (0.3) kPa at peak exercise to 14.8 (0.3) kPa three minutes into recovery (p < 0.001). Arterial carbon dioxide tension was unchanged. In the remaining three patients there was considerable arterial hypoxaemia on exercise, from 10.4 kPa at rest to 7.7 kPa at peak exercise. All of these patients had an alternative diagnosis (patent foramen ovale with right to left shunt during exercise, pulmonary embolic disease, and clinically unsuspected obstructive airways disease).
CONCLUSION: Patients with a presumptive diagnosis of chronic heart failure should undergo exercise testing with arterial blood gas analysis. Arterial hypoxaemia on exercise is rare in stable chronic heart failure. If hypoxia on exercise is detected, an alternative diagnosis should be sought.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8043331      PMCID: PMC1025446          DOI: 10.1136/hrt.71.6.528

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  8 in total

1.  Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities.

Authors:  M J Sullivan; M B Higginbotham; F R Cobb
Journal:  Circulation       Date:  1988-03       Impact factor: 29.690

2.  Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure.

Authors:  N P Buller; P A Poole-Wilson
Journal:  Br Heart J       Date:  1990-05

3.  Arterial oxygenation and arterial oxygen transport in chronic myocardial failure at rest, during exercise and after hydralazine treatment.

Authors:  S A Rubin; H V Brown; H J Swan
Journal:  Circulation       Date:  1982-07       Impact factor: 29.690

4.  Relation between hemodynamic and ventilatory responses in determining exercise capacity in severe congestive heart failure.

Authors:  J A Franciosa; C L Leddy; M Wilen; D E Schwartz
Journal:  Am J Cardiol       Date:  1984-01-01       Impact factor: 2.778

5.  Ventilation and gas exchange during exercise in severe chronic heart failure.

Authors:  S A Rubin; H V Brown
Journal:  Am Rev Respir Dis       Date:  1984-02

Review 6.  The mechanisms underlying the increased ventilatory response to exercise in chronic stable heart failure.

Authors:  A Clark; A Coats
Journal:  Eur Heart J       Date:  1992-12       Impact factor: 29.983

7.  Determinants of variable exercise performance among patients with severe left ventricular dysfunction.

Authors:  M B Higginbotham; K G Morris; E H Conn; R E Coleman; F R Cobb
Journal:  Am J Cardiol       Date:  1983-01-01       Impact factor: 2.778

8.  Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure.

Authors:  D P Moore; A R Weston; J M Hughes; C M Oakley; J G Cleland
Journal:  Lancet       Date:  1992-04-04       Impact factor: 79.321

  8 in total
  11 in total

Review 1.  Origin of symptoms in chronic heart failure.

Authors:  A L Clark
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

Review 2.  Exercise and heart failure: assessment and treatment.

Authors:  Andrew L Clark
Journal:  Heart       Date:  2006-05       Impact factor: 5.994

3.  Diagnosis of heart failure.

Authors:  J Cleland
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

Review 4.  Role of exercise ventilation in the limitation of functional capacity in patients with congestive heart failure.

Authors:  M Metra; L Dei Cas
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

5.  A possible role for systemic hypoxia in the reactive component of pulmonary hypertension in heart failure.

Authors:  Bryan J Taylor; Cesar R Mojica; Thomas P Olson; Paul R Woods; Robert P Frantz; Bruce D Johnson
Journal:  J Card Fail       Date:  2013-01       Impact factor: 5.712

Review 6.  The control of adrenergic function in heart failure: therapeutic intervention.

Authors:  A L Clark; J G Cleland
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

7.  The effects of alpha and beta blockade on ventilatory responses to exercise in chronic heart failure.

Authors:  K K A Witte; S D R Thackray; N P Nikitin; J G F Cleland; A L Clark
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

8.  Anatomical dead space, ventilatory pattern, and exercise capacity in chronic heart failure.

Authors:  A L Clark; T P Chua; A J Coats
Journal:  Br Heart J       Date:  1995-10

9.  Exercise intolerance in pulmonary arterial hypertension.

Authors:  Robin M Fowler; Kevin R Gain; Eli Gabbay
Journal:  Pulm Med       Date:  2012-06-10

10.  Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: a cohort study.

Authors:  J Michael Wells; Raul San Jose Estepar; Merry-Lynn N McDonald; Surya P Bhatt; Alejandro A Diaz; William C Bailey; Francine L Jacobson; Mark T Dransfield; George R Washko; Barry J Make; Richard Casaburi; Edwin J R van Beek; Eric A Hoffman; Frank C Sciurba; James D Crapo; Edwin K Silverman; Craig P Hersh
Journal:  BMC Pulm Med       Date:  2016-12-01       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.